Invitris
YC W23Munich, DE · Founded 2022 · 6 employees · 2 known investors
Find your way into Invitris
1,925 people in our graph share verified history with the Invitris team — schools, employers, funds. One of them is your warm intro.
Nicole Gaudelliunlockedknows Patrick Grossmann · together at Harvard University (overlapped)
knows the team · via Technical University of Munich
×7knows the team · via Y Combinator
knows the team · via Dana-Farber Cancer Institute
knows the team · via Maastricht University
knows the team · via Collège des Ingénieurs
Invitris develops cell-free protein synthesis platforms that enable rapid design, expression, and scalable production of complex proteins for biopharmaceuticals, industrial biotechnology, and agriculture.
Founders & leadership· Y Combinator alumni (W23)
Invitris was founded in 2022 by Patrick Grossmann and Kilian Vogele.
PG
Patrick Grossmannin𝕏CEO & Co-FounderPatrick Grossmann studied bioinformatics at Harvard Medical School and ETH Zurich, and holds a PhD and MBA. He co-founded Invitris to develop tools for accelerating drug development focused on combating antibiotic resistance.
KV
Kilian VogeleinCTO & Co-FounderHe holds a PhD in synthetic biology from TUM and has authored five patents.
Investors · 2
Competitors · 1
by search overlap
Companies competing with Invitris for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Invitris do?
- Invitris develops cell-free protein synthesis platforms that enable rapid design, expression, and scalable production of complex proteins for biopharmaceuticals, industrial biotechnology, and agriculture.
- Who founded Invitris?
- Invitris was founded by Patrick Grossmann, Kilian Vogele in 2022.
- Who are Invitris's investors?
- Invitris's investors include Y Combinator, 10x Founders.
- Where is Invitris headquartered?
- Invitris is headquartered in Munich, DE.